
About Biomiicron
Biomiicron is a Healthcare company based in Chennai (India) founded in 1998. It develops and produces pharmaceutical drugs for various medical categories including antiviral and pediatric care. It operates on a B2B model. The company has 108 employees. Its Indian entity Biomiicron Pharma India Private Limited reported revenue of ₹10.49 Cr. Biomiicron offers products and services including Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and Hi-Q. Its focus areas include Health, Pharmaceuticals, Nutraceuticals and Health Supplements. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Biomiicron Pharma is a pharmaceutical company based in Chennai, India, specializing in developing and manufacturing a wide range of health products. It offers items such as antiviral tablets, syrups for gastroenterology, gynecological treatments, and pediatric solutions through its manufacturing plants. The company emphasizes quality management and research to serve healthcare needs, focusing on categories like pain management and respiratory care.
- Headquarters Chennai, India
- Employees 108
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biomiicron.in
- Social X Facebook Instagram YouTube
- Legal Name Biomiicron Pharma India Private Limited
- Date of Incorporation 28 Jun, 2012
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹10.49 Cr
FY 2024 · -1% YoY
- Net Loss-₹72,690
FY 2024 · 0% margin
- EBITDA₹22.7 Lakh
FY 2024 · 2% margin
- Employee Count108
Associated legal entities of Biomiicron
Biomiicron operates through Biomiicron Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biomiicron Pharma India Private Limited CIN U52100TN2012PTC086554 | Active | 28 Jun 2012 | Chennai, Tamil Nadu | ₹10.5 Cr | 108 | 2 | View details |
Products & Services of Biomiicron
Biomiicron offers a comprehensive portfolio of products and services, including Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and Hi-Q.
Tablet for treating viral infections and supporting immune health.
Syrup formulation for antiviral care in patients.
Product for gastrointestinal relief and digestive support.
Supplement for gynecological health and wellness needs.
Treatment aid for infertility issues and reproductive care.
Medication for intensive care and toxin management.
Nutritional tablet for general health enhancement.
Topical gel for pain relief and inflammation control.
Preparation for pediatric health and child treatment.
Product for respiratory relief and symptom management.
Apps and channels of Biomiicron
its YouTube channel biomiicron pharma has 83 subscribers and 5 videos.
Videos from Biomiicron
The most watched videos on Biomiicron's YouTube channel, biomiicron pharma (83 subscribers). Click a video to play it here.
More on biomiicron pharma.
Board of directors of Biomiicron Pharma India Private Limited (Biomiicron)
Biomiicron Pharma India Private Limited is the primary company behind Biomiicron. The board of Biomiicron Pharma India Private Limited currently have 2 directors; the longest-serving is Suresh Kumar, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suresh Kumar DIN 02231888 | Director | 28 Jun 2012 | 14 yrs 4 mo | Biomiicron Pharma India Private Limited |
| Ketchaani Rajan Makesh DIN 01380057 | Director | 28 Jun 2012 | 14 yrs 4 mo | Biomiicron Pharma India Private Limited |
Financials of Biomiicron
Figures of Biomiicron Pharma India Private Limited, the primary company behind Biomiicron, for FY 2024. Revenue was ₹10.49 Cr (-1% year on year). Net loss was -₹72,690 (0% margin). EBITDA was ₹22.7 Lakh (2% margin). Revenue has grown at a compounded annual rate of +7% over three years and +3% over five years.
- ₹10.49 CrRevenue · FY 2024 · -1% YoY
- -₹72,690Net loss · 0% margin
- ₹22.7 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
- 108Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biomiicron Pharma India Private Limited are on its company page.
Detailed financial statements for Biomiicron
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Biomiicron
Biomiicron has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Biomiicron
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Biomiicron (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 55.41 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 56.21 M | 144 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biomiicron
Biomiicron was founded in 1998.
Biomiicron is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Biomiicron has 108 employees.
The primary company behind Biomiicron, Biomiicron Pharma India Private Limited, reported revenue of ₹10.49 Cr for FY 2024, down 1% year on year.
Biomiicron Pharma is a pharmaceutical company based in Chennai, India, specializing in developing and manufacturing a wide range of health products. It offers items such as antiviral tablets, syrups for gastroenterology, gynecological treatments, and pediatric solutions through its manufacturing plants. The company emphasizes quality management and research to serve healthcare needs, focusing on categories like pain management and respiratory care.
Biomiicron's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Biomiicron offers Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and 6 more products and services.
Biomiicron operates through Biomiicron Pharma India Private Limited.
The legal entities of Biomiicron currently have 2 directors, including Suresh Kumar, Ketchaani Rajan Makesh.